
Here are the top stories covered by DocWire News this week in the Hematology & Oncology section. This week, a study found that cancer has surpassed heart disease as the No. 1 cause of death in certain wealthy countries, mushrooms may reduce the risk of prostate cancer, and more.
Cancer has now surpassed heart disease as the leading cause of death in Sweden, Canada, Chile, Argentina, Poland, and Turkey, according to a report published in The Lancet.
A phase I/II study published in JAMA Oncology found that the HIV protease inhibitor Viracept® (nelfinavir mesylate) administered with concurrent chemoradiotherapy improved survival in patients with locally advanced non-small cell lung cancer.
A study published in the International Journal of Cancer observed an inverse relationship between mushroom consumption and incident prostate cancer, “suggesting that habitual mushroom intake might help to prevent prostate cancer,” the researchers said.
The incidence of colorectal cancer has increased in young adults in nine high-income countries spanning three continents, according to a study published in Gut. The researchers said this could be due to “changes in early-life exposures that influence large bowel carcinogenesis.”
Despite concerns of disease- or treatment-associated immunosuppression, a study published in the Journal of Clinical Oncology supports the recommendation for influenza vaccination in patients with cancer.
In case you missed it, more hem/onc headlines are featured below:
- New Guidelines Regarding the Role of Radiation Therapy in Pancreatic Cancer Treatment
- Harvard Research Links PTSD to Increased Risks of Ovarian Cancer
- Targeting Breast Cancer Gene for Childhood Liver Cancer Treatment
- Can Aspirin Improve Cancer Outcomes?
- Obesity Linked to Poor Psychosocial Health Outcomes in Breast and Prostate Cancer Patients